Pharma companies

GlaxoSmithKline Pharma Q3 profit dips 33% at Rs 53 crore

GlaxoSmithKline Pharma Q3 profit dips 33% at Rs 53 crore

GlaxoSmithKline Pharmaceuticals on Saturday reported 32.91 percent decline in net profit at Rs 52.95 crore for the quarter ended December 31, on account of mandatory price cuts as well as demonetisation.

Feb 11, 2017, 17:02 PM IST
Govt moves Supreme Court seeking ban on Crocin, D Cold Total, Corex, other combination drugs

Govt moves Supreme Court seeking ban on Crocin, D Cold Total, Corex, other combination drugs

The government has moved Supreme Court challenging the Delhi high court order scrapping ban on popular drugs(fixed-dose-combination drugs)such as Corex, Saridon and Vicks Action 500, D Cold Total, Ascoril-C, and many more in December.

Jan 30, 2017, 12:29 PM IST

Pricing pressure in US to keep pharma cos' growth under check

 Pharma companies are likely to report sequentially flat EBITDA growth in 3QFY17, impacted by pricing pressure and higher R&D expenditure, a report said.

Jan 15, 2017, 13:51 PM IST
Indian pharma companies' profiles better than global peers: Moody's

Indian pharma companies' profiles better than global peers: Moody's

The Indian pharmaceutical companies exhibit strong business profiles underpinned by good products and geographic diversity as compared to some global peers, American rating agency Moody`s said on Friday.

Nov 25, 2016, 16:14 PM IST
Relief for pharma cos as Delhi HC stays ban on drugs till March 28

Relief for pharma cos as Delhi HC stays ban on drugs till March 28

Delhi High Court on Monday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon.

Mar 21, 2016, 15:45 PM IST
Drugs to become cheaper as panel recommends putting cap on trade margins

Drugs to become cheaper as panel recommends putting cap on trade margins

For drugs priced between Rs 20-50, the panel has proposal to cap the margin at 40 percent.

Mar 09, 2016, 18:35 PM IST

Drug pricing: Don't take coercive steps against pharma companies, says HC

Delhi High Court today told the government not to take any coercive action against pharma companies, including Novartis India Limited and Cipla Ltd, in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.

Nov 24, 2015, 21:19 PM IST

India drugmaker stocks exception in Asian rout

Continued strength in the dollar when the Federal Reserve raises interest rates will also boost their income. More than 40 percent of over-the-counter and generic prescription drugs sold in the United States come from India.

Sep 03, 2015, 08:14 AM IST

Pharmexcil sees $1.2 billion export hit from EU ban

India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.

Jul 27, 2015, 18:39 PM IST

Focus on getting Ranbaxy's plants USFDA nod one at a time: Sun Pharma

The Mumbai-based drug major, which acquired Ranbaxy in a USD 4 billion deal, feels it is important for the merged entity to "re-establish" the trust between Ranbaxy and the US Food and Drug Administration (USFDA).

Jun 07, 2015, 14:41 PM IST

Drug makers' tax benefit claim on freebies, gifts unlawful: CAG

Slamming the practice of pharma companies offering freebies and gifts to doctors, government auditor CAG said that drug makers have claimed tax benefits on such expenses despite these being prohibited by law.

May 10, 2015, 14:36 PM IST

NPPA warns drug cos over non-registration with online database

With just 41 out of top 100 pharma firms responding to its direction to register for online database, drug price regulator NPPA has warned to take action if the rest of the companies did not comply with its order immediately.

May 04, 2015, 21:59 PM IST
Sun Pharma gets US FTC clearance for Ranbaxy acquisition

Sun Pharma gets US FTC clearance for Ranbaxy acquisition

The early termination of the waiting period under the HSR Act satisfies one of the essential conditions to the closing of the Ranbaxy acquisition, it added.

Feb 02, 2015, 11:14 AM IST

Pharma in 2014: Deals worth billions and fines worth millions

It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including the high profile Sun-Ranbaxy merger.

Dec 26, 2014, 11:27 AM IST

Sun Pharma, Ranbaxy to sell 7 products to meet CCI conditions

While approving their USD 4-billion merger, Competition Commission of India (CCI) has asked the two companies to divest seven products to address anti-competitive concerns.

Dec 08, 2014, 20:26 PM IST

OTC drug market to reach $6.6 bn by 2016

India's pharmaceuticals industry accounts for about 2.4 percent of the global pharma industry by value and 10 percent by volume.

Oct 05, 2014, 12:17 PM IST

CCI expands probe into Sun-Ranbaxy deal; seeks public scrutiny

This is probably the first instance where the CCI has ordered a public scrutiny of a proposed merger and acquisition (M&A) deal to ensure compliance to fair trade regulations.

Aug 28, 2014, 11:04 AM IST

Top 20 pharma companies' capex to surge by 40%: CRISIL

India's top 20 pharmaceutical companies would increase capital expenditure by 40 percent to more than Rs 50,000 crore by fiscal 2018, credit rating agency CRISIL said Wednesday.

Aug 13, 2014, 20:11 PM IST

Sun Pharma-Ranbaxy deal gets BSE, NSE clearance

The combination of Sun Pharma and Ranbaxy creates the fifth-largest speciality generics company in the world and the largest pharmaceutical company in India.

Jul 21, 2014, 13:33 PM IST

Price cut: Drug makers' profitability may come under pressure

Among MNCs, Sanofi Aventis, Abbott and Pfizer are also likely to be affected owing to their sizeable share exposure on anti-diabetic segment and Indian market in general.

Jul 20, 2014, 12:42 PM IST